Navigation Links
Khosla Ventures and BIOeCON Form KiOR Inc.
Date:11/1/2007

Technology Development for the Conversion of Biomass to Bio-oil

MENLO PARK, California and HOEVELAKEN, The Netherlands, November 1 /PRNewswire/ -- Khosla Ventures and BIOeCON announce today the formation of their joint venture KiOR Inc. Khosla Ventures, will provide the Series A funding, whereas BIOeCON will bring its knowledge and intellectual property for the 'Biomass Catalytic Cracking Process' (BCC). KiOR Inc. will focus on the further development and commercialization of the BCC technology as well as prepare for raising significantly more capital in the next two to three years.

BCC technology converts lignocellulosic biomass, found in grass, wood, and various agricultural and forestry wastes, into a bio-oil product that can be further upgraded to transportation fuels. The conversion of cellulosic biomass to bio-oil represents a significant commercial opportunity that also offers important benefits, including using post-harvesting waste rather than competing with food crops; promoting environmental sustainability; reducing reliance on fossil fuels such as crude oil; and enabling economic development and job creation in rural areas.

"The key technical problem in the conversion of cellulosic biomass into usable fuels is how to open up the inaccessible solid fibrous 'woody' material, so that it can be effectively transformed. Most of the existing processes to unlock the woody structures are quite costly and intensive of energy or chemicals," says Paul O'Connor, founder and president of BIOeCON. "BIOeCON has developed a simple non-energy intensive way to make the woody biomass accessible to catalysts and convert to a bio-oil product with significantly improved product properties compared to other thermal-chemical processes.

Doug Cameron, Khosla Ventures' Chief Scientific Advisor: "BIOeCON has a strong R&D network and solid scientific fundamentals. We have done a thorough evaluation of the technology and research programs and believe this can be a breakthrough technology."

"Securing funding from a strategic and visionary venture capital company like Khosla Ventures is a major step forward", says Rob van der Meij, CEO of KiOR Inc." Khosla's experience and expertise in technology startups is unmatched in the industry and we are looking forward to the acceleration that Khosla Ventures no doubt will bring."

KiOR's concept and approach is unique and has the potential to become a large scale, widely applied technology, that can improve energy availability and sustainability to both the developed and developing world. The BCC technology unlocks the energy of vast amounts of biomass waste and converts it into a high valued energy product. This will not only reduce net carbon dioxide emission, but can also improve the energy independence of many countries.

About BIOeCON

BIOeCON was founded in 2006 by Paul O'Connor with the aim to develop new, large scale technology to convert biomass, particularly the recalcitrant polymeric biomass residue, in a more efficient and cost-effective way to valuable molecules which can be utilized by the chemical and energy industry. BIOeCON is a privately funded company, which operates through an international network of top-scientists and institutions to bring together know-how, expertise and experience from heterogeneous catalysis, biomass processing, process development and technology commercialization. BIOeCON is based in Hoevelaken, the Netherlands.

http://www.bio-e-con.com

About Khosla Ventures

Khosla Ventures offers venture assistance, strategic advice and capital to entrepreneurs. The firm helps entrepreneurs extend the potential of the Internet to new markets such as mobile and supports breakthrough scientific work such as bio refineries. Vinod Khosla founded the firm in 2004 and was joined in 2006 by two partners. The partners have been involved in founding or growing billion dollar businesses such as Sun Microsystems, Juniper Networks and AOL. Vinod has been labeled the #1 VC multiple times by Forbes and Fortune recently labeled him as one of the nation's most influential ethanol advocates, noting "there are venture capitalists, and then there's Vinod Khosla." The firm's capital comes entirely from its own partners and a portion of all profits are donated to charitable causes, with an emphasis on micro-finance, education, the environment and affordable housing. Khosla Ventures is based in Menlo Park, California, USA.

http://www.khoslaventures.com


'/>"/>
SOURCE BIOeCON
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Tech companies get commerce loans for new ventures
2. Conference will focus on financing of early-stage ventures
3. Badger Ventures plans to fund IT; partisan stem-cell battle; BadgerNet draws fire
4. New Madison VC firm Badger Ventures looks for next big IT entrepreneurs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... , ... The new and improved Oakton® pocket testers, from Cole-Parmer, stand up ... a new cap design that is versatile, functional and leakproof. They are ideal for ... water quality. , The Oakton pocket testers have many user-friendly and functional features. An ...
(Date:9/19/2017)... -- ValGenesis Inc., the global leader in Enterprise Validation ... strategic partnership with VTI Life Sciences (VTI). This partnership ... the latest technology available in the ValGenesis VLMS system. ... and cost-effective validation services using ValGenesis VLMS. VTI will ... system. The partnership ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in ... analysis to isolate single cells and provide visual documentation of monoclonality for use ...
(Date:9/19/2017)... NC (PRWEB) , ... September 19, 2017 , ... ... on band technologies for surgical applications, announced today that two new patents have ... , Michael Albert, MD, Co-Founder of Band-LOK, said, “We continue to explore additional ...
Breaking Biology Technology:
(Date:8/23/2017)... public,s help is being enlisted in what,s thought to be the biggest ... human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to date ... project's goal is to help advance scientific knowledge of the role of ... The ...
(Date:8/15/2017)... ivWatch LLC , a medical device company focused on improving the ... its ISO 13485 Certification, the global standard for medical device quality ... ... device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates ...
(Date:7/20/2017)... 2017 Delta (NYSE: DAL ) customers now can ... at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan ... Delta,s biometric boarding pass experience that ... now integrated into the boarding process to allow eligible Delta SkyMiles Members ...
Breaking Biology News(10 mins):